Overall EBITDA per bed for Q2 FY26 was ₹73.4 lakh, compared with ₹71.2 lakh in Q2 FY25 and ₹68.5 lakh in Q1 FY26. EBITDA per bed for existing units was ₹76.5 lakh, representing a 7% YoY increase. Shares of Max Healthcare Institute Ltd ended at ₹1,101.90, up by ₹3.90, or 0.36%, on the BSE.
